ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,903Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 63

$536K Total Retail Price of All Prescriptions

Rank: 7 out of 63

368 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 368 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

4% of this provider’s 368 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

0% of this provider’s 8,304 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
LISINOPRIL 361 340 1 2
LEVOTHYROXINE SODIUM 350 347 2 1
SIMVASTATIN 330 314 3 5
AMLODIPINE BESYLATE 312 304 4 3
FUROSEMIDE 229 228 5 4
HYDROCHLOROTHIAZIDE 226 198 6 15
ATORVASTATIN CALCIUM 214 198 7 10
OMEPRAZOLE 181 168 8 6
METFORMIN HCL 180 155 9 17
METOPROLOL TARTRATE 177 177 10 7
PRAVASTATIN SODIUM 142 141 11 16
LOSARTAN POTASSIUM 137 134 12 20
METOPROLOL SUCCINATE 128 125 13 13
DONEPEZIL HCL 123 123 14 14
SERTRALINE HCL 122 117 15 19
TAMSULOSIN HCL 120 120 16 26
TRAZODONE HCL 117 116 17 18
NAMENDA 109 109 18 24
AMLODIPINE BESYLATE-BENAZEPRIL 100 83 19 83
ALLOPURINOL 90 86 20 55
ALENDRONATE SODIUM 89 89 21 46
TRAMADOL HCL 87 72 22 12
CARVEDILOL 86 82 23 39
KLOR-CON M20 85 77 24 31
POTASSIUM CHLORIDE 81 79 25 30
ZOLPIDEM TARTRATE 78 74 26 40
ADVAIR DISKUS 74 70 27 42
GABAPENTIN 73 53 28 21
NEXIUM 69 69 29 72
MIRTAZAPINE 65 64 30 8
ATENOLOL 65 65 30 22
WARFARIN SODIUM 64 55 32 9
CITALOPRAM HBR 64 55 32 11
METFORMIN HCL ER 62 58 34 73
CYMBALTA 56 19 35 43
JANUVIA 55 54 36 107
RANITIDINE HCL 54 54 37 27
LANTUS 53 53 38 29
PANTOPRAZOLE SODIUM 50 50 39 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 14, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.